SEOM clinical guidelines for the treatment of non-small cell lung cancer (2018)
Majem, Margarita (Institut d'Investigació Biomèdica Sant Pau)
Juan, Óscar (Hospital Universitari i Politècnic La Fe (València))
Insa, Amelia (Hospital Clínic Universitari (València))
Reguart, Noemi (Hospital Clínic i Provincial de Barcelona)
Trigo, J. M. (Hospital Universitario Virgen de la Victoria (Màlaga, Andalusia))
Carcereny, Enric (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
García-Campelo, Rosario (Complejo Hospitalario Universitario de A Coruña)
García García, Yolanda (Universitat Autònoma de Barcelona. Departament de Medicina)
Guirado, M. (Hospital General Universitario de Elche)
Provencio, M. (Hospital Universitario Puerta de Hierro Majadahonda (Madrid))
Universitat Autònoma de Barcelona

Date:	2018
Abstract:	Non-small cell lung cancer (NSCLC) accounts for up to 85% of all lung cancers. The last few years have seen the development of a new staging system, diagnostic procedures such as liquid biopsy, treatments like immunotherapy, as well as deeper molecular knowledge; so, more options can be offered to patients with driver mutations. Groups with specific treatments account for around 25% and demonstrate significant increases in overall survival, and in some subgroups, it is important to evaluate each treatment alternative in accordance with scientific evidence, and even more so with immunotherapy. New treatments similarly mean that we must reconsider what should be done in oligometastatic disease where local treatment attains greater value.
Rights:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.
Language:	Anglès
Document:	Article ; recerca ; Versió publicada
Subject:	NSCLC ; Chemotherapy ; Immunotherapy ; Targeted therapies ; Radiotherapy
Published in:	Clinical & translational oncology, Vol. 21 (november 2018) , p. 3-17, ISSN 1699-3055

DOI: 10.1007/s12094-018-1978-1
PMID: 30446985

15 p, 955.9 KB

The record appears in these collections:
Research literature > UAB research groups literature > Research Centres and Groups (research output) > Health sciences and biosciences > Institut d'Investigació en Ciencies de la Salut Germans Trias i Pujol (IGTP)
Research literature > UAB research groups literature > Research Centres and Groups (research output) > Health sciences and biosciences > Institut de Recerca Sant Pau
Articles > Research articles
Articles > Published articles